No doubt in my mind there is a place for micro dosing, at this stage it's just full dose under supervision, cannabis took 6 years to get to $100m to $200m. (my guess)
A LOT of people in Australia are daily users of cannabis, comparatively a huge market, by comparison this is a tiny market and will take years to resolve.
Take the small, less frequent dose, small group for target indication, and strict (and expensive) clinical setting, I'm sitting on my cash on this one.
Ann: Psilocybin and MDMA down-scheduled, page-20
Add LGP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.003(2.13%) |
Mkt cap ! $34.83M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $31.66K | 274.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 135447 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 31600 | 1 |
View Market Depth
| Last trade - 15.50pm 08/11/2024 (20 minute delay) ? |
| LGP (ASX) Chart |